Executive Summary
This digest covers 50 significant federal contract modifications ($10M+) with a combined obligation of $1,935,265,219, none of which are defense-related; the entire stream is civilian-agency spending led by VA, HHS, DHS, USDA and GSA.
The dominant themes are VA facilities construction (many small SDVOSB set-asides), CDC/CMS IT and health services, DHS/CBP and USCIS IT and aviation-adjacent work, and USDA Forest Service wildfire airtanker services. The single largest record, TriWest Healthcare Alliance's $900,485,186 VA delivery order, carries a one-month performance period and $0 outlayed, so its headline value is not a reliable revenue indicator. The average signal strength is 3.1/10 and no contract was classified as bullish or bearish, so conviction is low across the stream; the highest-conviction read is the consistent pattern of small-business and SDVOSB set-aside construction awards to private firms with no public-market linkage. The key watch item is outlay conversion: most recent awards show $0 outlayed, and many records lack public-parent identification, which limits translation into listed-equity impact.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Significant Contract Modifications ($10M+) digest from October 01, 2026.
Investment Signals (8)
- TriWest Healthcare Alliance $900.5M VA delivery order to monitor for recurrence (LOW)▲
TriWest received a $900,485,186 VA delivery order with a one-month performance period (2026-09-01 to 2026-09-30) and $0 outlayed, described as an 'EXPRESS REPORT: FY26 SEPTEMBER' order. Whether this recurs in future periods determines whether it is a material revenue stream.
- Abbott Laboratories BARDA TBI diagnostic clinical validation contract (MEDIUM)▲
Abbott received a $65,469,510 firm-fixed-price BARDA contract (base-plus-options $83,713,826) to support an FDA submission for an expanded TBI test indication, with $17,555,624 outlayed and a term to 2029-11-15. Successful FDA clearance would extend the diagnostic's commercial scope, though the data does not confirm approval.
- Anduril Industries CBP Air and Marine delivery order with 66% outlay (MEDIUM)▲
Anduril received DHS/CBP Air and Marine Contracting Division Delivery Order 18 for $42,066,939, with $27,713,957 outlayed and about $14.4M remaining through 2027-06-30. Full and open competition with a firm fixed price suggests a competitive win on border technology work.
- Booz Allen Hamilton GSA order largely unexecuted at $0 outlay (MEDIUM)▲
Booz Allen's GSA FAS time-and-materials order carries $38,452,810 obligated against a $373,036,880 ceiling, with $0 outlayed and only about 10% of potential value committed. Execution and option exercise are unproven.
- Accenture Federal Services CBP cybersecurity operations at $0 outlay (MEDIUM)▲
Accenture Federal Services received a $14,823,471 firm-fixed-price CBP Cyber Security Operations Center order within a $121,415,324 ceiling, with $0 outlayed and performance starting 2026-09-24. Value beyond current obligation depends on option exercise.
- Salient CRGT/GOVCIO USCIS IT order only 15% obligated against ceiling (MEDIUM)▲
Salient CRGT received a $23,895,601 USCIS time-and-materials delivery order within a $163,395,565 base-plus-options ceiling, with $12,213,285 outlayed. Only about 15% of the ceiling is obligated, so most value depends on future option exercise, and the high pricing risk rating reflects this uncertainty.
- Priority Fulfillment Services contract scope unclear versus NAICS codes (LOW)▲
Priority Fulfillment Services received a $29,062,442 U.S. Mint delivery order described only as 'USPS TRUST ACCOUNT', while its NAICS 518210 and PSC DA01 codes suggest IT services. The mismatch leaves the scope and revenue quality unverified.
- Basilea Pharmaceutica BARDA antibiotic contract ceiling far above obligation (MEDIUM)▲
Basilea's BARDA cost-sharing contract carries $45,192,122 obligated against a $191,938,367 base-plus-options ceiling (about 24% obligated), with roughly $20.3M outlayed and the through date of 2027-12-31. Pricing risk is rated high, and option exercise is required to reach the full ceiling.
Get daily alerts with 8 investment signals and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Significant Contract Modifications ($10M+)
September 30, 2026
Significant Contract Modifications ($10M+) — September 30, 2026
September 29, 2026
Significant Contract Modifications ($10M+) — September 29, 2026
September 28, 2026
Significant Contract Modifications ($10M+) — September 28, 2026
September 27, 2026
Significant Contract Modifications ($10M+) — September 27, 2026
🇺🇸 More from United States
View all →October 02, 2026
US Pre-Market SEC Filings Roundup — October 02, 2026
US Pre-Market SEC Filings Roundup
October 02, 2026
Nasdaq 100 Stocks SEC Filings — October 02, 2026
Nasdaq 100 Stocks SEC Filings
October 02, 2026
US Merger & Acquisition SEC Filings — October 02, 2026
US Merger & Acquisition SEC Filings
October 02, 2026
USA Insider Trading Pulse — October 02, 2026
USA Insider Trading Pulse